Tricyclic nucleoside analogues as antiherpes agents
Tricyclic (T) guanine analogues are a class of compounds in which the N1 and N 2 atoms of the guanine system are linked by etheno bridge to form the 3,9-dihydro-9-oxo-5H-imidazo[1,2-a]purine system. Almost 70 tricyclic derivatives of guanine-type potent antiherpetic agents acyclovir (ACV), ganciclov...
Gespeichert in:
| Veröffentlicht in: | Antiviral research 2006-09, Vol.71 (2), p.134-140 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 140 |
|---|---|
| container_issue | 2 |
| container_start_page | 134 |
| container_title | Antiviral research |
| container_volume | 71 |
| creator | Golankiewicz, Bozenna Ostrowski, Tomasz |
| description | Tricyclic (T) guanine analogues are a class of compounds in which the N1 and N
2 atoms of the guanine system are linked by etheno bridge to form the 3,9-dihydro-9-oxo-5H-imidazo[1,2-a]purine system. Almost 70 tricyclic derivatives of guanine-type potent antiherpetic agents acyclovir (ACV), ganciclovir (GCV) and 9-{[cis-1′,2′-bis(hydroxymethyl)cycloprop-1′-yl]methyl}guanine were synthesized and evaluated for activity against viruses of the herpes family. Here, we review the most successful compounds in terms of their antiviral activity and physico-chemical properties. These features are modulated by the kind and position of additional substituents present in the appended third ring of aglycone. The best antiherpetic activity–fluorescence combinations as well as activity of compounds in comparison to parent congeners are summarized. The data presented indicate that compounds of the 6-(4-RPh) family are of particular importance because of their advantageous antiviral potency, increased lipophilicity and good or moderate fluorescence properties. |
| doi_str_mv | 10.1016/j.antiviral.2006.05.004 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68767774</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0166354206001318</els_id><sourcerecordid>68767774</sourcerecordid><originalsourceid>FETCH-LOGICAL-c430t-d4aed7604f7d7ba316c968784e465162116a867903a0671e3e472a07c991a8823</originalsourceid><addsrcrecordid>eNqFkE1LAzEQhoMoWqt_QXvR266Tj02yRxG_oOBFz2HMTjVlu1uTbaH_3pQWPRYGhoFnZl4exq45lBy4vpuX2A1hHSK2pQDQJVQlgDpiI26NKGqo9TEbZVIXslLijJ2nNIcMmtqesjOujc1INWLyPQa_8W3wk27lW-pTaGiCHbb914rSBHPlT98Ul9vpi7ohXbCTGbaJLvd9zD6eHt8fXorp2_Prw_208ErCUDQKqTEa1Mw05hMl177W1lhFSldcC8412hwIJOZcnCQpIxCMr2uO1go5Zre7u8vY_-Qwg1uE5KltsaN-lVw-po0x6iAoQEtZaZtBswN97FOKNHPLGBYYN46D24p1c_cn1m3FOqhcFps3r_YvVp8Lav739iYzcLMHMHlsZxE7H9I_Z0ELoerM3e84yubWgaJLPlDnqQmR_OCaPhwM8wuUCJlD</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20633568</pqid></control><display><type>article</type><title>Tricyclic nucleoside analogues as antiherpes agents</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Golankiewicz, Bozenna ; Ostrowski, Tomasz</creator><creatorcontrib>Golankiewicz, Bozenna ; Ostrowski, Tomasz</creatorcontrib><description>Tricyclic (T) guanine analogues are a class of compounds in which the N1 and N
2 atoms of the guanine system are linked by etheno bridge to form the 3,9-dihydro-9-oxo-5H-imidazo[1,2-a]purine system. Almost 70 tricyclic derivatives of guanine-type potent antiherpetic agents acyclovir (ACV), ganciclovir (GCV) and 9-{[cis-1′,2′-bis(hydroxymethyl)cycloprop-1′-yl]methyl}guanine were synthesized and evaluated for activity against viruses of the herpes family. Here, we review the most successful compounds in terms of their antiviral activity and physico-chemical properties. These features are modulated by the kind and position of additional substituents present in the appended third ring of aglycone. The best antiherpetic activity–fluorescence combinations as well as activity of compounds in comparison to parent congeners are summarized. The data presented indicate that compounds of the 6-(4-RPh) family are of particular importance because of their advantageous antiviral potency, increased lipophilicity and good or moderate fluorescence properties.</description><identifier>ISSN: 0166-3542</identifier><identifier>EISSN: 1872-9096</identifier><identifier>DOI: 10.1016/j.antiviral.2006.05.004</identifier><identifier>PMID: 16780965</identifier><identifier>CODEN: ARSRDR</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Acyclovir ; Acyclovir - analogs & derivatives ; Acyclovir - chemistry ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antiviral agents ; Antiviral Agents - chemical synthesis ; Antiviral Agents - chemistry ; Antiviral Agents - pharmacology ; Antivirals ; Biological and medical sciences ; Fluorescence ; Ganciclovir ; Ganciclovir - analogs & derivatives ; Ganciclovir - chemistry ; Herpes simplex viruses ; Herpesviridae - classification ; Herpesviridae - drug effects ; Herpesviridae Infections - virology ; Human viral diseases ; Humans ; Infectious diseases ; Medical sciences ; Microbial Sensitivity Tests ; Pharmacology. Drug treatments ; Tricyclic analogues ; Viral diseases ; Viral diseases with cutaneous or mucosal lesions and viral diseases of the eye</subject><ispartof>Antiviral research, 2006-09, Vol.71 (2), p.134-140</ispartof><rights>2006 Elsevier B.V.</rights><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c430t-d4aed7604f7d7ba316c968784e465162116a867903a0671e3e472a07c991a8823</citedby><cites>FETCH-LOGICAL-c430t-d4aed7604f7d7ba316c968784e465162116a867903a0671e3e472a07c991a8823</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0166354206001318$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18062249$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16780965$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Golankiewicz, Bozenna</creatorcontrib><creatorcontrib>Ostrowski, Tomasz</creatorcontrib><title>Tricyclic nucleoside analogues as antiherpes agents</title><title>Antiviral research</title><addtitle>Antiviral Res</addtitle><description>Tricyclic (T) guanine analogues are a class of compounds in which the N1 and N
2 atoms of the guanine system are linked by etheno bridge to form the 3,9-dihydro-9-oxo-5H-imidazo[1,2-a]purine system. Almost 70 tricyclic derivatives of guanine-type potent antiherpetic agents acyclovir (ACV), ganciclovir (GCV) and 9-{[cis-1′,2′-bis(hydroxymethyl)cycloprop-1′-yl]methyl}guanine were synthesized and evaluated for activity against viruses of the herpes family. Here, we review the most successful compounds in terms of their antiviral activity and physico-chemical properties. These features are modulated by the kind and position of additional substituents present in the appended third ring of aglycone. The best antiherpetic activity–fluorescence combinations as well as activity of compounds in comparison to parent congeners are summarized. The data presented indicate that compounds of the 6-(4-RPh) family are of particular importance because of their advantageous antiviral potency, increased lipophilicity and good or moderate fluorescence properties.</description><subject>Acyclovir</subject><subject>Acyclovir - analogs & derivatives</subject><subject>Acyclovir - chemistry</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antiviral agents</subject><subject>Antiviral Agents - chemical synthesis</subject><subject>Antiviral Agents - chemistry</subject><subject>Antiviral Agents - pharmacology</subject><subject>Antivirals</subject><subject>Biological and medical sciences</subject><subject>Fluorescence</subject><subject>Ganciclovir</subject><subject>Ganciclovir - analogs & derivatives</subject><subject>Ganciclovir - chemistry</subject><subject>Herpes simplex viruses</subject><subject>Herpesviridae - classification</subject><subject>Herpesviridae - drug effects</subject><subject>Herpesviridae Infections - virology</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Medical sciences</subject><subject>Microbial Sensitivity Tests</subject><subject>Pharmacology. Drug treatments</subject><subject>Tricyclic analogues</subject><subject>Viral diseases</subject><subject>Viral diseases with cutaneous or mucosal lesions and viral diseases of the eye</subject><issn>0166-3542</issn><issn>1872-9096</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1LAzEQhoMoWqt_QXvR266Tj02yRxG_oOBFz2HMTjVlu1uTbaH_3pQWPRYGhoFnZl4exq45lBy4vpuX2A1hHSK2pQDQJVQlgDpiI26NKGqo9TEbZVIXslLijJ2nNIcMmtqesjOujc1INWLyPQa_8W3wk27lW-pTaGiCHbb914rSBHPlT98Ul9vpi7ohXbCTGbaJLvd9zD6eHt8fXorp2_Prw_208ErCUDQKqTEa1Mw05hMl177W1lhFSldcC8412hwIJOZcnCQpIxCMr2uO1go5Zre7u8vY_-Qwg1uE5KltsaN-lVw-po0x6iAoQEtZaZtBswN97FOKNHPLGBYYN46D24p1c_cn1m3FOqhcFps3r_YvVp8Lav739iYzcLMHMHlsZxE7H9I_Z0ELoerM3e84yubWgaJLPlDnqQmR_OCaPhwM8wuUCJlD</recordid><startdate>20060901</startdate><enddate>20060901</enddate><creator>Golankiewicz, Bozenna</creator><creator>Ostrowski, Tomasz</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7TM</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20060901</creationdate><title>Tricyclic nucleoside analogues as antiherpes agents</title><author>Golankiewicz, Bozenna ; Ostrowski, Tomasz</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c430t-d4aed7604f7d7ba316c968784e465162116a867903a0671e3e472a07c991a8823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Acyclovir</topic><topic>Acyclovir - analogs & derivatives</topic><topic>Acyclovir - chemistry</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antiviral agents</topic><topic>Antiviral Agents - chemical synthesis</topic><topic>Antiviral Agents - chemistry</topic><topic>Antiviral Agents - pharmacology</topic><topic>Antivirals</topic><topic>Biological and medical sciences</topic><topic>Fluorescence</topic><topic>Ganciclovir</topic><topic>Ganciclovir - analogs & derivatives</topic><topic>Ganciclovir - chemistry</topic><topic>Herpes simplex viruses</topic><topic>Herpesviridae - classification</topic><topic>Herpesviridae - drug effects</topic><topic>Herpesviridae Infections - virology</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Medical sciences</topic><topic>Microbial Sensitivity Tests</topic><topic>Pharmacology. Drug treatments</topic><topic>Tricyclic analogues</topic><topic>Viral diseases</topic><topic>Viral diseases with cutaneous or mucosal lesions and viral diseases of the eye</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Golankiewicz, Bozenna</creatorcontrib><creatorcontrib>Ostrowski, Tomasz</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Antiviral research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Golankiewicz, Bozenna</au><au>Ostrowski, Tomasz</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tricyclic nucleoside analogues as antiherpes agents</atitle><jtitle>Antiviral research</jtitle><addtitle>Antiviral Res</addtitle><date>2006-09-01</date><risdate>2006</risdate><volume>71</volume><issue>2</issue><spage>134</spage><epage>140</epage><pages>134-140</pages><issn>0166-3542</issn><eissn>1872-9096</eissn><coden>ARSRDR</coden><abstract>Tricyclic (T) guanine analogues are a class of compounds in which the N1 and N
2 atoms of the guanine system are linked by etheno bridge to form the 3,9-dihydro-9-oxo-5H-imidazo[1,2-a]purine system. Almost 70 tricyclic derivatives of guanine-type potent antiherpetic agents acyclovir (ACV), ganciclovir (GCV) and 9-{[cis-1′,2′-bis(hydroxymethyl)cycloprop-1′-yl]methyl}guanine were synthesized and evaluated for activity against viruses of the herpes family. Here, we review the most successful compounds in terms of their antiviral activity and physico-chemical properties. These features are modulated by the kind and position of additional substituents present in the appended third ring of aglycone. The best antiherpetic activity–fluorescence combinations as well as activity of compounds in comparison to parent congeners are summarized. The data presented indicate that compounds of the 6-(4-RPh) family are of particular importance because of their advantageous antiviral potency, increased lipophilicity and good or moderate fluorescence properties.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>16780965</pmid><doi>10.1016/j.antiviral.2006.05.004</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0166-3542 |
| ispartof | Antiviral research, 2006-09, Vol.71 (2), p.134-140 |
| issn | 0166-3542 1872-9096 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_68767774 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Acyclovir Acyclovir - analogs & derivatives Acyclovir - chemistry Antibiotics. Antiinfectious agents. Antiparasitic agents Antiviral agents Antiviral Agents - chemical synthesis Antiviral Agents - chemistry Antiviral Agents - pharmacology Antivirals Biological and medical sciences Fluorescence Ganciclovir Ganciclovir - analogs & derivatives Ganciclovir - chemistry Herpes simplex viruses Herpesviridae - classification Herpesviridae - drug effects Herpesviridae Infections - virology Human viral diseases Humans Infectious diseases Medical sciences Microbial Sensitivity Tests Pharmacology. Drug treatments Tricyclic analogues Viral diseases Viral diseases with cutaneous or mucosal lesions and viral diseases of the eye |
| title | Tricyclic nucleoside analogues as antiherpes agents |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T21%3A52%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tricyclic%20nucleoside%20analogues%20as%20antiherpes%20agents&rft.jtitle=Antiviral%20research&rft.au=Golankiewicz,%20Bozenna&rft.date=2006-09-01&rft.volume=71&rft.issue=2&rft.spage=134&rft.epage=140&rft.pages=134-140&rft.issn=0166-3542&rft.eissn=1872-9096&rft.coden=ARSRDR&rft_id=info:doi/10.1016/j.antiviral.2006.05.004&rft_dat=%3Cproquest_cross%3E68767774%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20633568&rft_id=info:pmid/16780965&rft_els_id=S0166354206001318&rfr_iscdi=true |